Trained immunity causes myeloid cell hypercoagulability.

Saved in:
Bibliographic Details
Title: Trained immunity causes myeloid cell hypercoagulability.
Authors: Rehill AM; Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.; National Children's Research Centre, Our Lady's Children's Hospital Crumlin, Dublin, Ireland., McCluskey S; Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.; National Children's Research Centre, Our Lady's Children's Hospital Crumlin, Dublin, Ireland., Ledwith AE; School of Biochemistry and Immunology, Trinity College Dublin, Dublin, Ireland., Ryan TAJ; School of Biochemistry and Immunology, Trinity College Dublin, Dublin, Ireland., Ünlü B; Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland., Leon G; Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.; National Children's Research Centre, Our Lady's Children's Hospital Crumlin, Dublin, Ireland., Charles-Messance H; School of Biochemistry and Immunology, Trinity College Dublin, Dublin, Ireland., Gilbert EH; Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.; FutureNeuro SFI Research Centre, Royal College of Surgeons in Ireland, Dublin, Ireland., Klavina P; Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.; National Children's Research Centre, Our Lady's Children's Hospital Crumlin, Dublin, Ireland., Day EA; School of Biochemistry and Immunology, Trinity College Dublin, Dublin, Ireland., Coppinger J; Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland., O'Sullivan JM; Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland., McMahon C; National Children's Research Centre, Our Lady's Children's Hospital Crumlin, Dublin, Ireland., O'Donnell JS; Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland., Curtis AM; Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland., O'Neill LAJ; School of Biochemistry and Immunology, Trinity College Dublin, Dublin, Ireland., Sheedy FJ; School of Biochemistry and Immunology, Trinity College Dublin, Dublin, Ireland., Preston RJS; Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.; National Children's Research Centre, Our Lady's Children's Hospital Crumlin, Dublin, Ireland.
Source: Science advances [Sci Adv] 2025 Mar 07; Vol. 11 (10), pp. eads0105. Date of Electronic Publication: 2025 Mar 07.
Publication Type: Journal Article
Journal Info: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2375-2548 (Electronic) Linking ISSN: 23752548 NLM ISO Abbreviation: Sci Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2375-2548
DOI:10.1126/sciadv.ads0105